Literature DB >> 23951498

A SNP in SRC-1 reduces bone density in tamoxifen-treated women.

.   

Abstract

Entities:  

Year:  2012        PMID: 23951498      PMCID: PMC3727779          DOI: 10.1038/bonekey.2012.117

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN: 2047-6396


× No keyword cloud information.
  1 in total

1.  A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone.

Authors:  R J Hartmaier; A S Richter; R M Gillihan; J Z Sallit; S E McGuire; J Wang; A V Lee; C K Osborne; B W O'Malley; P H Brown; J Xu; T C Skaar; S Philips; J M Rae; F Azzouz; L Li; J Hayden; N L Henry; A T Nguyen; V Stearns; D F Hayes; D A Flockhart; S Oesterreich
Journal:  Mol Endocrinol       Date:  2011-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.